Keratan sulfate in body fluids in joint disease
DOI:
https://doi.org/10.3109/17453679509157662Abstract
Keratan sulfate (KS) is a highly-negatively charged glycosaminoglycan which is found principally in aggrecan, the most abundant proteoglycan in the extracellular matrix of hyaline, fibrous and elastic cartilage. In 1985, we discovered that small peptidoglycans bearing antigenic KS (agKS) were present in small amounts in human serum and postulated that the great majority of these were derived from the degradation of cartilage aggrecan (Thonar et al. 1985). During the past decade, studies of antigenic KS in joint fluid and serum have provided strong evidence in support of this hypothesis. By asking questions which could not have been addressed previously, these studies have shed new light upon the metabolism of aggrecan in vivo. In this manuscript, we describe some of these findings and put in perspective their contribution to our understanding of the metabolism of aggrecan in joint diseases.Downloads
Download data is not yet available.
Downloads
Published
1995-01-01
How to Cite
Thonar, E. J.-M. A., Masuda, K., Häuselmann, H. J., Uebelhart, D., Lenz, M. E., & Manicourt, D. H. (1995). Keratan sulfate in body fluids in joint disease. Acta Orthopaedica, 66(sup266), 103–106. https://doi.org/10.3109/17453679509157662
Issue
Section
Articles
License
Acta Orthopaedica (Scandinavica) content is available freely online as from volume 1, 1930. The journal owner owns the copyright for all material published until volume 80, 2009. As of June 2009, the journal has however been published fully Open Access, meaning the authors retain copyright to their work. As of June 2009, articles have been published under CC-BY-NC or CC-BY licenses, unless otherwise specified.
